| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/04/2011 | WO2011091716A1 Epidermal growth factor receptor variant |
| 08/04/2011 | WO2011070214A3 Conjugates and compositions for immunotherapy and anti-tumor treatment |
| 08/04/2011 | WO2011064758A3 Fusion proteins of immunoglobulin fc and interferon- alpha |
| 08/04/2011 | WO2011022725A3 Mimotopes of hiv and uses thereof |
| 08/04/2011 | WO2010045586A8 Muc-1 cytoplasmic domain peptides as inhibitors of cancer |
| 08/04/2011 | US20110190812 Fibrinogen-based tissue adhesive containing an elastase inhibitor |
| 08/04/2011 | US20110190730 Methods of inducing pluripotency involving oct4 protein |
| 08/04/2011 | US20110190729 Methods of inducing pluripotency involving sox2 protein |
| 08/04/2011 | US20110190725 Method for altering drug pharmacokinetics based on medical delivery platform |
| 08/04/2011 | US20110190688 Permeant Delivery System and Methods for Use Thereof |
| 08/04/2011 | US20110190476 Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha |
| 08/04/2011 | US20110190474 Antimicrobial peptides and derived metapeptides |
| 08/04/2011 | US20110190473 Leptin peptide antagonists |
| 08/04/2011 | US20110190382 Treatment of Cancer by Inhibition of IGFBPs and Clusterin |
| 08/04/2011 | US20110190377 Method for producing a cell and/or tissue and/or disease phase specific medicament |
| 08/04/2011 | US20110190370 Modulation of hif1(alpha) and hif2(alpha) expression |
| 08/04/2011 | US20110190224 Non-Viral Delivery of Compounds to Mitochondria |
| 08/04/2011 | US20110190223 Hemcm42 nucleic acids |
| 08/04/2011 | US20110190222 Selective Inhibition of Polyglutamine Protein Expression |
| 08/04/2011 | US20110190221 Modulation and repletion/enhancement of the complement system for treatment of trauma |
| 08/04/2011 | US20110190220 Use of Defensin Alpha 1 and/or Defensin Alpha 4, as a Marker for Predicting Treatment Response and/or a Relapse in a Patient Suffering form Chronic Myeloid Leukemia |
| 08/04/2011 | US20110190219 Treating cancer with granulocyte-macrophage colony stimulating factor |
| 08/04/2011 | US20110190218 Bag-1 peptide that inhibits prostate cancer |
| 08/04/2011 | US20110190217 Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic epo short peptides |
| 08/04/2011 | US20110190216 Materials and methods for treatment of spinal muscular atrophy and taxane-induced peripheral neuropathy (tipn) |
| 08/04/2011 | US20110190215 Therapeutic use of peptides |
| 08/04/2011 | US20110190214 Advantageous Salts of Mu-Opiate Receptor Peptides |
| 08/04/2011 | US20110190213 Retro-inverso peptides derived from interleukin-3 |
| 08/04/2011 | US20110190212 Cyclic tetrapeptides |
| 08/04/2011 | US20110190211 Cyclopentaquinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 08/04/2011 | US20110190210 Prominin-1 peptide fragments and uses thereof |
| 08/04/2011 | US20110190209 Conjugates having a releasable linkage |
| 08/04/2011 | US20110190208 Medical use of the radical scavenger and antioxidant alpha-1-microglobulin |
| 08/04/2011 | US20110190207 Inhibiting binding of fgf23 to the binary fgfr-klotho complex for the treatment of hypophosphatemia |
| 08/04/2011 | US20110190206 Reducing myocardial reperfusion injury by the combination therapy of protein kinase a activation and b1-adrenergic receptor blockade |
| 08/04/2011 | US20110190205 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 08/04/2011 | US20110190204 Taxane- and Taxoid-Protein Compositions |
| 08/04/2011 | US20110190203 Ophthalmic Compositions Containing A Synergistic Combination Of Two Polymers |
| 08/04/2011 | US20110190202 Prevention of Cellular Senescence in Mammals by Natural Peptide Complexes |
| 08/04/2011 | US20110190201 Method, device, and kit for maintaining physiological levels of steroid hormone in a subject |
| 08/04/2011 | US20110190200 GLUCAGON ANALOGS EXHIBITING ENHANCED SOLUBILITY AND STABILITY IN PHYSIOLOGICAL pH BUFFERS |
| 08/04/2011 | US20110190199 Combination Therapy for Tuberculosis |
| 08/04/2011 | US20110190198 Peptide sequnces, their branched form and use thereof for antimicrobial applications |
| 08/04/2011 | US20110190197 Plant derived antibiotic peptide rich in glycine |
| 08/04/2011 | US20110190196 Improved peptide mediators of cholesterol efflux |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/04/2011 | US20110190194 Preparation and composition of inter-alpha proteins from blood |
| 08/04/2011 | US20110190193 Treatment of endothelial dysfunction in diabetic patients |
| 08/04/2011 | US20110190192 Methods for treating erectile dysfunction in patients with insulin-dependent diabetes |
| 08/04/2011 | US20110190144 Novel compositions and methods for the treatment of psoriasis |
| 08/04/2011 | US20110190138 Methods and compositions for treating conditions |
| 08/04/2011 | US20110189773 Silk fibroin fiber bundles for matrices in tissue engineering |
| 08/04/2011 | US20110189769 Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis |
| 08/04/2011 | US20110189706 Process for the measurement of the potency of glatiramer acetate |
| 08/04/2011 | US20110189651 Method and Device for Detecting Feline Immunodeficiency Virus |
| 08/04/2011 | US20110189306 COMPOUNDS, COMPOSITIONS AND TREATMENTS FOR V-ATPase RELATED DISEASES |
| 08/04/2011 | US20110189304 Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
| 08/04/2011 | US20110189299 Pharmaceutical composition containing surface-coated microparticles |
| 08/04/2011 | US20110189290 Compositions Comprising Capture Peptides for A B-Amyloid Peptide |
| 08/04/2011 | US20110189268 Inhibition of Placenta Growth Factor (PLGF) Mediated Metastasis and/or Angiogenesis |
| 08/04/2011 | US20110189264 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 08/04/2011 | US20110189263 Peptides that target dorsal root ganglion neurons |
| 08/04/2011 | US20110189257 Nanoparticle based therapy for aggregating mucin |
| 08/04/2011 | US20110189253 Biomaterial composition and method |
| 08/04/2011 | US20110189219 Sialic acid to support the immune system in the elderly |
| 08/04/2011 | US20110189214 Cdca1 epitope peptides and vaccines containing the same |
| 08/04/2011 | US20110189213 Mybl2 epitope peptides and vaccines containing the same |
| 08/04/2011 | US20110189207 Methods for soluble zalpha11 cytokine receptors |
| 08/04/2011 | US20110189205 Methods of treating cancer using an agent that modulates activity of the calcitonin-gene related peptide ("cgrp") receptor |
| 08/04/2011 | US20110189204 Treatment of Disease with Proteasone Inhibitors |
| 08/04/2011 | US20110189202 Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll |
| 08/04/2011 | US20110189201 Modulation of bone development |
| 08/04/2011 | US20110189199 Methods for p2ry5 mediated regulation of hair growth and mutants thereof |
| 08/04/2011 | US20110189188 Novel gp96 derived peptides |
| 08/04/2011 | US20110189187 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/04/2011 | US20110189184 Modulation of neural stem cells and neural progenitor cells |
| 08/04/2011 | US20110189181 Use of agents derived from CEACAM1 for the treatment of inflammatory diseases |
| 08/04/2011 | US20110189176 Methods of treating diseases with dll4 antagonists |
| 08/04/2011 | US20110189168 Antibody-induced apoptosis |
| 08/04/2011 | US20110189166 Methods of treating hemorheologic abnormalities in mammals |
| 08/04/2011 | US20110189165 Method of identifying disease risk factors |
| 08/04/2011 | US20110189164 Peptide Stabilizer Compounds and Screening Method |
| 08/04/2011 | US20110189163 Compositions and Methods for Treating Collagen-Mediated Diseases |
| 08/04/2011 | US20110189162 Modified Clostridial Toxins Comprising an Integrated Protease Cleavage Site-Binding Domain |
| 08/04/2011 | US20110189161 Nutrigenomics methods and compositions |
| 08/04/2011 | US20110189160 Veterinary Topical Agent |
| 08/04/2011 | US20110189159 Methods and compositions for protein delivery |
| 08/04/2011 | US20110189158 Clostridial neurotoxins with altered persistency |
| 08/04/2011 | US20110189157 Use of human hyaluronidases for axonal regrowth |
| 08/04/2011 | US20110189156 Method for Treating Systemic Bacterial, Fungal and Protozoan Infection |
| 08/04/2011 | US20110189155 Large Form Of Human 2',5'-Oligoadenylate Synthetase OAS3 for Preventing or Treating Infection With Positive-Sense Single-Stranded RNA Viruses |
| 08/04/2011 | US20110189154 Applications For A New Class Of Enzymes: Sulfiredoxins |
| 08/04/2011 | US20110189153 Compositions and Methods for Treating Collagen-Mediated Diseases |
| 08/04/2011 | US20110189151 Compositions and methods for prolonging survival of platelets |
| 08/04/2011 | US20110189141 Multiple target t cell receptor |
| 08/04/2011 | US20110189140 Compositions and Methods for Tissue Repair with Extracellular Matrices |
| 08/04/2011 | US20110189139 Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide |
| 08/04/2011 | US20110189136 Uses and isolation of very small embryonic-like (vsel) stem cells |
| 08/04/2011 | US20110189131 Active variants of the il-18 binding protein and medical uses thereof |
| 08/04/2011 | US20110189130 Dihydropyrazolopyrimidinone derivatives |